Melanotan I 10mg
LatestLOT MI0002
99.88%HPLC purity · meets spec
- Labeled
- 10mg
- Measured
- 10.3mg
- Identity
- Confirmed
- Heavy metals
- Not Detected
- Sterility
- No Growth
- Endotoxin
- < 0.05 EU/mL
- Tested
- Jul 30, 2026
8 assays passed · ISO/IEC 17025 accredited
Peptide
Melanotan I
CAS: 75921-69-6MT-1MT-I
A 13-amino acid linear peptide analog of alpha-melanocyte-stimulating hormone that selectively activates MC1R to stimulate eumelanin synthesis and photoprotective pathways in clinical studies. Premium Direct-Supply Peptide.
MassChoose an option
Quantity
From$49
Fast, protected deliveryTracked USA shipping with discreet packaging.
Tracked USA delivery
Free shipment protection
Priority shipping available
Verified Test Results
Every batch, independently verified.
Each batch is analyzed by an ISO/IEC 17025 accredited third-party laboratory. The report below reflects the identity, purity and full-panel specification data reported by the lab.
ILSILS LaboratoriesCertificate of Analysis≥99%Purity by HPLC
ISO 17025 Accredited8× Tested
ParameterResultMethodSpecification
Peptide Purity (HPLC)99.88%HPLC>= 95%
Net Peptide Content10.3mgHPLCReport
Identity (HPLC)ConfirmedHPLCMeets spec
AppearanceGoodVisualMeets spec
Fentanyl ScreenNot DetectedImmunoassayPass
Heavy Metals (ICP-MS)Not DetectedICP-MSPass
Sterility (PCR)No GrowthPCRPass
Endotoxin (USP <85>)< 0.05 EU/mLUSP <85>Reported
Third-Party Verified
Certificate of Analysis
Every lot is HPLC-tested at an ISO/IEC 17025-accredited lab. Open any batch's certificate below.
Frequently Paired Products
Products commonly selected alongside this item
Compound Information
Technical specifications
MOLECULAR PROFILE
What Is Melanotan I?
Synthetic linear tridecapeptide analog of α-MSHLinear Peptideα-MSH Analog
- Type
- Synthetic linear peptide
- CAS Number
- 75921-69-6
- Molecular Formula
- C78H111N21O19
- Molecular Weight
- 1646.8 g/mol
- Amino Acids
- 13
- Sequence
- Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2
STORAGE REQUIREMENTS
Stability Information
Store refrigeratedProtect from lightReconstitute with amino h2o
Lyophilized (powder)2-8°Cstable for years
Reconstituted2-8°C
Product Guides & References
Verified publications and source documentation
NEW ENGLAND JOURNAL OF MEDICINE
Afamelanotide for Erythropoietic Protoporphyria
2015•DOI: 10.1056/NEJMoa1411481•PMID: 26106947Langendonk JG, Balwani M, Anderson KE, et al.
View Source CLINICAL PHARMACOKINETICSPharmacokinetics and Pharmacodynamics of Afamelanotide and its Clinical Use in Dermatology
2017•DOI: 10.1007/s40262-016-0501-5•PMID: 28063031Minder EI, Barman-Aksoezen J, Schneider-Yin X.
View Source JOURNAL OF DRUGS IN DERMATOLOGYAfamelanotide: An Orphan Drug with Potential for Broad Dermatologic Applications
2021•PMID: 33683075Wu R, Cotliar J.
View Source CLINICALTRIALS.GOV
